Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chiara Boroni"'
Autor:
Filippo Milazzo, Salvatore Trunfio, Roberto Paino, Jonica Campolo, Alessandro Verde, Chiara Boroni, Maria Frigerio, Claudio Russo, Oberdan Parodi, Marina Parolini, Luigi Martinelli, Raffaele Caruso
Publikováno v:
Cytokine
This study investigates the impact of early left ventricular (LV)-mechanical unloading on systemic oxidative stress and inflammation in terminal heart failure patients and their impact both on multi organ failure and on intensive care unit (ICU) stay
Autor:
Oberdan Parodi, Chiara Boroni, Daniela Giannessi, Filippo Milazzo, Marina Parolini, Manuela Cabiati, Raffaele Caruso, Claudio Russo, Maria Frigerio, Chiara Caselli, Jonica Campolo
Publikováno v:
Circulation Journal
BACKGROUND Redox aminothiols have been reported to modulate the activity of recombinant metalloproteinases (MMP). The aim of the present study was to investigate the effects of myocardial redox state on the activities of MMP-2 and -9 implicated in ca
Autor:
Renata Baffelli, Ilaria S. Pagani, E Mattarucchi, Francesco Pasquali, Silvia Lilliu, Diana Pigni, Federica Bolda, Orietta Spinelli, Cristina Pirrone, Elisabetta Amelotti, Chiara Boroni, Ursula Giussani, Tamara Intermesoli, Arnalda Lanfranchi, Eleonora Candi, Fulvio Porta, Francesco Lo Curto, Alessandro Rambaldi, Luigi Caimi, Giovanni Porta
Publikováno v:
Oncoscience
Europe PubMed Central
Europe PubMed Central
Imatinib mesylate (IM) is the first line therapy against Chronic Myeloid Leukemia, effectively prolonging overall survival. Because discontinuation of treatment is associated with relapse, IM is required indefinitely to maintain operational cure. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6f1487ba77d4d9e16b2f5d343a69b4
http://hdl.handle.net/2108/113620
http://hdl.handle.net/2108/113620
Autor:
Claudia Vittori, Filippo Milazzo, Silvia Del Ry, Oberdan Parodi, Luigi Martinelli, Alessandro Verde, Marina Parolini, Maria Frigerio, Manuela Cabiati, Roberto Paino, Daniela Giannessi, Chiara Boroni, Raffaele Caruso
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 31(6)
Background Inflammatory mechanisms are associated with worse prognosis in end-stage heart failure (ESHF) patients who require left ventricular assist device (LVAD) support. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS
Autor:
Cristina Barlassina, Alessandro Rambaldi, Diana Pigni, Francesco Pasquali, Giovanni Porta, Arnalda Lanfranchi, Cristina Pirrone, Ilaria S. Pagani, Matteo Barcella, Tamara Intermesoli, Sara Lupoli, Federica Bolda, Francesco Lo Curto, Chiara Boroni, Francesca D'Avila, Fulvio Porta, Orietta Spinelli, Ursula Giussani
Publikováno v:
Blood. 122:1316-1316
Introduction Imatinib mesylate (IM) is the first line therapy against Chronic Myeloid Leukemia (CML), effectively prolonging overall survival. Because discontinuation of treatment is associated with molecular relapse, IM is required indefinitely to m